Home › Cardiovascular Disease › Kansas › Topeka
Cardiovascular Disease clinical trials in Topeka, KS
5 studies for Cardiovascular Disease are looking for participants at sites in and around Topeka (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Cotton O'Neil Diabetes & Endocrinology Center, Topeka
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Topeka
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Cotton O Neil Clinical Res Center, Topeka
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RecruitingPhase 4Healthy volunteers welcome
- VA Eastern Kansas Healthcare System, Topeka
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Topeka
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- San Francisco, CA18 studies
Other studies in Topeka
- Steatotic Liver Disease7 studies
- Prostate Cancer7 studies
- Overweight7 studies
- Non-Small Cell Lung Cancer7 studies
- Obesity6 studies
- Breast Cancer6 studies
- Crohn's Disease6 studies
- Lung Cancer6 studies
- Type 2 Diabetes5 studies
- Bladder Cancer4 studies
- Esophageal Cancer4 studies
- Melanoma4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.